================================================================================
                    MEMORANDUM OF ASSOCIATION
                              OF
                  BIOPHARMA INDUSTRIES LIMITED
================================================================================

                         [Pursuant to Section 4(1) of the Companies Act, 2013
                          and Rule 13 of the Companies (Incorporation) Rules, 2014]

--------------------------------------------------------------------------------

I. NAME CLAUSE
--------------

The name of the Company is "BIOPHARMA INDUSTRIES LIMITED"

--------------------------------------------------------------------------------

II. REGISTERED OFFICE CLAUSE
---------------------------

The Registered Office of the Company will be situated in the State of Maharashtra.

Current Registered Office Address:
Plot No. 234-235, MIDC Industrial Area
Thane-Belapur Road, Rabale
Thane - 400701
Maharashtra, India

--------------------------------------------------------------------------------

III. OBJECTS CLAUSE
-------------------

A. THE MAIN OBJECTS TO BE PURSUED BY THE COMPANY ON ITS INCORPORATION ARE:

1. PHARMACEUTICAL MANUFACTURING AND TRADING

   (a) To manufacture, produce, process, formulate, compound, synthesize, pack,
       import, export, buy, sell, trade and deal in all kinds of pharmaceutical
       preparations, medicines, drugs, tablets, capsules, syrups, suspensions,
       emulsions, injections, injectables, infusions, eye drops, ear drops,
       nasal preparations, ointments, creams, gels, lotions, suppositories,
       powders, granules, aerosols, patches, implants, medical devices, and
       all other pharmaceutical, medicinal and healthcare products and
       preparations in accordance with all applicable drug laws and regulations.

   (b) To manufacture, produce, process, import, export, buy, sell and deal in
       Active Pharmaceutical Ingredients (APIs), bulk drugs, drug intermediates,
       excipients, pharmaceutical grade chemicals, and all raw materials and
       packing materials used in pharmaceutical manufacturing.

   (c) To manufacture, process and deal in nutraceuticals, dietary supplements,
       vitamins, minerals, herbal preparations, ayurvedic medicines, and other
       health and wellness products.

   (d) To undertake contract manufacturing, toll manufacturing, loan license
       manufacturing for other pharmaceutical companies in accordance with
       applicable regulations.

2. REGULATORY COMPLIANCE AND CERTIFICATIONS

   (a) To obtain, apply for, maintain, renew and hold drug manufacturing
       licenses under the Drugs and Cosmetics Act, 1940 and Rules thereunder
       from Central and State Drug Regulatory Authorities.

   (b) To obtain and maintain import/export licenses, WHO-GMP certifications,
       US FDA registrations and approvals, EU GMP certifications, TGA approvals
       (Australia), Health Canada approvals, ANVISA (Brazil) registrations,
       and all other national and international regulatory approvals required
       for pharmaceutical manufacturing, import and export.

   (c) To obtain product registrations, marketing authorizations, and import
       permits in India and in foreign countries for pharmaceutical products.

   (d) To comply with Schedule M of the Drugs and Cosmetics Rules (Good
       Manufacturing Practices), ICH guidelines, PIC/S standards, and all
       applicable national and international quality and safety standards.

   (e) To maintain pharmacovigilance systems, report adverse drug reactions,
       conduct post-marketing surveillance, and comply with drug safety
       regulations.

3. RESEARCH AND DEVELOPMENT

   (a) To establish and operate research and development laboratories for
       formulation development, analytical method development, process
       development, and drug delivery system research.

   (b) To conduct bioequivalence studies, bioavailability studies, stability
       studies, dissolution studies, and all other studies required for
       product approval and registration.

   (c) To conduct clinical trials in accordance with DCGI regulations, ICH-GCP
       guidelines, and other applicable clinical research regulations.

   (d) To develop generic formulations, novel drug delivery systems, controlled
       release formulations, and other innovative pharmaceutical products.

   (e) To file Abbreviated New Drug Applications (ANDAs) with US FDA, Marketing
       Authorization Applications (MAAs) with EU authorities, and equivalent
       applications with other regulatory authorities.

4. QUALITY CONTROL AND QUALITY ASSURANCE

   (a) To establish and operate quality control laboratories for testing of
       raw materials, in-process materials, finished products, and stability
       samples.

   (b) To develop and validate analytical methods, manufacturing processes,
       cleaning procedures, and other quality-critical processes.

   (c) To maintain quality management systems, documentation systems, change
       control systems, and deviation management systems.

   (d) To conduct internal audits, vendor audits, and quality reviews.

--------------------------------------------------------------------------------

B. MATTERS WHICH ARE NECESSARY FOR FURTHERANCE OF THE OBJECTS SPECIFIED IN
   CLAUSE III(A) ARE:

1. INTELLECTUAL PROPERTY

   (a) To apply for, obtain, purchase, license, or otherwise acquire patents,
       trademarks, trade names, copyrights, designs, technical know-how, trade
       secrets, and other intellectual property rights.

   (b) To license, assign, sell or otherwise dispose of intellectual property
       rights owned by the Company.

   (c) To defend intellectual property rights and to take legal action against
       infringement.

2. PROPERTY AND ASSETS

   (a) To purchase, take on lease, hire, or otherwise acquire land, buildings,
       manufacturing plants, warehouses, offices, laboratories, and other
       immovable properties.

   (b) To construct, alter, maintain, develop and improve buildings and
       structures for manufacturing, storage, administration, and other purposes.

   (c) To purchase, hire, lease or otherwise acquire plant and machinery,
       equipment, instruments, vehicles, furniture, and other movable properties.

   (d) To sell, mortgage, lease, or otherwise dispose of any property of the
       Company.

3. AGREEMENTS AND COLLABORATIONS

   (a) To enter into collaboration agreements, joint venture agreements,
       licensing agreements, technology transfer agreements, manufacturing
       agreements, distribution agreements, and marketing agreements with
       domestic and international pharmaceutical companies.

   (b) To act as agent, distributor, stockist, or representative of other
       pharmaceutical companies.

   (c) To appoint agents, distributors, stockists, and representatives for
       marketing and distribution of Company's products.

4. BORROWING AND FINANCING

   (a) To borrow or raise money for the purposes of the Company by issue of
       debentures, bonds, notes, or other debt instruments.

   (b) To create mortgage, charge, hypothecation, pledge or other security
       interest on any property of the Company.

   (c) To give guarantees, indemnities or provide security for obligations of
       subsidiaries or associated companies.

5. INVESTMENTS

   (a) To invest funds of the Company in shares, debentures, bonds, mutual
       funds, government securities, and other investments.

   (b) To acquire shares in other companies engaged in similar or related
       business and to hold, sell or otherwise deal with such investments.

   (c) To form subsidiaries, joint ventures, partnerships and other business
       arrangements.

6. HUMAN RESOURCES

   (a) To employ qualified pharmacists, scientists, technical staff, and other
       personnel required for the business of the Company.

   (b) To establish employee welfare schemes, provident fund, gratuity fund,
       superannuation fund, pension schemes, and other benefit plans.

   (c) To implement employee stock option schemes and other incentive programs.

7. GENERAL POWERS

   (a) To do all such other lawful things as are incidental or conducive to
       the attainment of the above objects.

   (b) To amalgamate with any other company having objects altogether or in
       part similar to those of this Company.

   (c) To distribute assets of the Company among members in specie or in kind.

--------------------------------------------------------------------------------

IV. LIABILITY CLAUSE
--------------------

The liability of the members is limited.

--------------------------------------------------------------------------------

V. CAPITAL CLAUSE
-----------------

The Authorized Share Capital of the Company is Rs. 50,00,00,000/- (Rupees
Fifty Crores only) divided into:

5,00,00,000 (Five Crore) Equity Shares of Rs. 10/- (Rupees Ten) each

The Company has power to increase, reduce or modify the capital and to divide
or sub-divide the shares and to issue shares of different classes including
preference shares and to attach thereto any preferential, qualified, deferred
or special rights, privileges, conditions or restrictions and to vary, modify
or abrogate such rights, privileges, conditions or restrictions and to
consolidate or subdivide shares.

--------------------------------------------------------------------------------

VI. DECLARATION
---------------

We, the several persons whose names and addresses are subscribed below, are
desirous of being formed into a Company in pursuance of this Memorandum of
Association, and we respectively agree to take the number of shares in the
capital of the Company set opposite our respective names:

--------------------------------------------------------------------------------
S.No. | Name, Address, Description | Shares | Signature | Date
      | and Occupation of          | Taken  |           |
      | Subscriber                 |        |           |
--------------------------------------------------------------------------------
1.    | Dr. Ramesh Narayan Kulkarni| 10,00,000| Sd/-    | 10-01-2012
      | 45, Hiranandani Gardens,   |        |           |
      | Powai, Mumbai - 400076     |        |           |
      | Businessman                |        |           |
--------------------------------------------------------------------------------
2.    | Mrs. Sunita Ramesh Kulkarni| 5,00,000 | Sd/-    | 10-01-2012
      | 45, Hiranandani Gardens,   |        |           |
      | Powai, Mumbai - 400076     |        |           |
      | Businesswoman              |        |           |
--------------------------------------------------------------------------------
3.    | Mr. Anil Shankar Joshi     | 5,00,000 | Sd/-    | 10-01-2012
      | 12, Raheja Residency,      |        |           |
      | Thane West - 400601        |        |           |
      | Professional               |        |           |
--------------------------------------------------------------------------------
      | TOTAL                      | 20,00,000|         |
--------------------------------------------------------------------------------

Witness to the above signatures:

Name: Mr. Prakash Mehta
Address: 78, Lawyers' Chambers, Fort, Mumbai - 400001
Occupation: Advocate

Signature: Sd/-
Date: 10-01-2012

================================================================================
                    END OF MEMORANDUM OF ASSOCIATION
================================================================================
